Inhibitors of Trypanothione Reductase
Inhibitors of Trypanothione Reductase
批准号:
6555410
负责人:
DAVID G ALBERG
金额:
$13.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-06-01 至 2007-05-31
关键词:
NAD(P)H oxidoreductase Trypanosomatina active sites antiprotozoal agents chemical structure function drug design /synthesis /production electrospray ionization mass spectrometry enzyme mechanism enzyme structure high performance liquid chromatography microorganism metabolism nuclear magnetic resonance spectroscopy oxidoreductase inhibitor spermidine sulfides thiols
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal focuses on the design, synthesis, and evaluation of potential inhibitors of trypanothione reductase (TR). TR is an NADPH-dependent flavoenzyme that catalyzes the reduction of the antioxidant trypanothione (N1, N8-bis (glutathionyl) spermidine) from its disulfide to its dithiol form. The enzyme is found in the trypanosomatid parasites, Trypanosoma and Leishmania, causative agents of a host of diseases of both humans and domestic animals. Examples include African sleeping sickness (Trypanosoma brucei), Chagas' disease (T. cruzi), and numerous leishmanial infections, such as oriental sore (Leishmania tropica) and kalazar (L. donovani). The health and economic effects of these diseases are enormous; however, truly effective treatments for them are lacking. Since its discovery in the mid-1980s, TR has emerged as a prime target for the development of antiparasitic drugs. Much attention has been focused on the identification of reversible TR inhibitors. While this study will add to that body of knowledge with a number of proposed competitive TR inhibitors, its primary focus is to identify mechanism-based irreversible inhibitors, a class of TR inhibitor that has received scant attention in the literature. The approach taken in the design of the proposed irreversible inhibitors is to prepare analogues of trypanothione that incorporate electrophilic moieties in place of the substrate's disulfide group. It is expected that the electrophilic inhibitors will form a covalent bond with a nucleophilic cysteine residue in the enzyme active site, which is known to be a key residue in the catalytic mechanism of TR. The experimental methods will be those of organic chemistry, in particular, nuclear magnetic resonance (NMR) spectroscopy and electro spray ionization (ESI) mass spectrometry will play a large role in the preparation and analysis of the proposed compounds. The inhibitory activity of potential inhibitors will be evaluated using both kinetic and mass spectrometric approaches. In particular, analysis of inhibited protein via HPLC/ESI ion trap MS/MS will be important in verifying the covalent nature of the proposed irreversible inhibitors. Carleton College undergraduate chemistry majors will carry out the research. The principal investigator has had significant experience in crafting successful undergraduate research experiences.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
The synthesis and inhibitory activity of dethiotrypanothione and analogues against trypanothione reductase.
脱硫锥硫酮及其类似物的合成及其对锥硫酮还原酶的抑制活性。
DOI:
10.1021/jo062597s
发表时间:
2007
期刊:
The Journal of organic chemistry
影响因子:
--
作者:
[Czechowicz,JosephineA, Wilhelm,AprilK, Spalding,MaroyaD, Larson,AnnaM, Engel,LinneaK, Alberg,DavidG]
通讯作者:
Alberg,DavidG
Synthesis and evaluation of substrate analogue inhibitors of trypanothione reductase.
锥硫酮还原酶底物类似物抑制剂的合成与评价。
DOI:
10.3109/14756366.2011.604319
发表时间:
2012
期刊:
Journal of enzyme inhibition and medicinal chemistry
影响因子:
5.6
作者:
[Duyzend,MichaelH, Clark,ChristopherT, Simmons,ShaynaL, Johnson,WadeB, Larson,AnnaM, Leconte,AaronM, Wills,AndrewW, Ginder-Vogel,Matthew, Wilhelm,AprilK, Czechowicz,JosephineA, Alberg,DavidG]
通讯作者:
Alberg,DavidG
DO CYCLOPHILIN & FK506 BINDING PROTEIN BIND B-TURNS?
-
批准号:3045600
-
项目类别:
-
资助金额:$1.22万
-
财政年份:1993
-
负责人:DAVID G ALBERG
-
依托单位:
DO CYCLOPHILIN & FK506 BINDING PROTEIN BIND B-TURNS?
-
批准号:3045601
-
项目类别:
-
资助金额:$2.27万
-
财政年份:1992
-
负责人:DAVID G ALBERG
-
依托单位:
DO CYCLOPHILIN & FK506 BINDING PROTEIN BIND B-TURNS?
-
批准号:3045599
-
项目类别:
-
资助金额:$2.0万
-
财政年份:1991
-
负责人:DAVID G ALBERG
-
依托单位: